Cell Surface Makers Market, By Products (Flow Cytometry, Hematology Analyzers, Cell Imaging Systems, and Reagents and Kits), By Applications (Disease Diagnosis, and Research and Drug Discovery), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI390120 | Publish Date: June 2023 | No. of Pages: 163

Global Cell Surface Makers Market Overview

Cell surface markets are proteins expressed on the cells’ surface and often serve as markers of particular cell types. Cell surface markers are usually molecules or antigens inside the plasma membrane of the cell. These markers are the chief components in the categorization and identification of cells including macrophages, lymphocytes, tumor cells, monocytes, and other cells primarily related to immunology. Cell surface market analysis can allow simplification of disease identification and diagnosis, drug discovery, and sample preparation. This analysis can take place with different samples, including blood, bone marrow, lymph nodes, and other tissues. The global cell surface makers market accounted for US$ 594.05 million in 2020 and is estimated to be US$ 1221.63 million by 2030 and is anticipated to register a CAGR of 7.50%.

Global Cell Surface Makers Market Dynamics

                                         

Use of advanced techniques

The factors that drive the growth of the global cell surface market are advancement in healthcare technology and growing inclination towards minimizing healthcare expenditure by reducing the cost associated with diagnosis. The increasing utilization of in vitro diagnostics, the rising automation in laboratories, the reduction in the cost of diagnosis, and the requirement for lowering healthcare expenditures globally are amongst the chief factors stimulating the market for cell surface markers.

High demands for new antibodies

 In addition, the rise of new markets will lead to a high demand for new antibodies, therefore boosting the demand for the global cell surface markers market. Furthermore, the rising occurrence of chronic diseases such as autoimmune disorders and cancer, the simplification of analysis procedures, and the rising automation of solutions and technologies are also amongst the major factors augmenting the growth of the global market. On the other hand, the complications involved in the utilization of flow cytometers and the negligence in making huge investments for gaining access to cutting-edge models are amongst the chief factors impeding the growth of the global market for cell surface markers.  Moreover, it has an opportunity in personalized medicine, in which it can help the physician decide the most effective therapy to be used for the patient.

Global Cell Surface Makers Market Segmentation

                                      

The global cell surface makers market is segmented based on product, application, and region.

Based on product, the global cell surface makers market is segmented into flow cytometry, hematology analyzers, and cell imaging systems, and reagents and kits. Flow Cytometer is the most widely used instrument due to availability of a variety of flow cytometers. Flow cytometers have proved to be efficacious in drug discovery as well as in research, which further fuels their demand. Based on application, the targeted global market is bifurcated into disease diagnosis, and research and drug discovery. Cell surface marker application in research and drug discovery is expected to dominate the target market as cell marker analysis is widely used by pharmaceutical manufacturers and researchers in their research and development process and in drug discovery.

Regional Insights:

                                        

Based on the region the global cell surface makers market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts highest revenue share to the global cell surface makers market due to growing demand for advanced medical technologies and increasing geriatric population. Asia Pacific cell surface makers market is projected to register a high CAGR over the forecast period owing to the growing trend of increasing number of life sciences research activities and government initiatives to boost the biotechnology and pharmaceutical industries in several Asian countries.

                                       

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2029

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Product Type- Flow Cytometry, Hematology Analyzers, And Cell Imaging Systems, And Reagents And Kits

By Application- Disease Diagnosis, And Research And Drug Discovery

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

 

 

Global Cell Surface Makers Market, By Product:

  • Flow Cytometry
  • Hematology Analyzers
  • Cell Imaging Systems
  • Reagents and Kits

Global Cell Surface Makers Market, By Application:

  • Disease Diagnosis
  • Research and Drug Discovery

Global Cell Surface Makers Market, By Region:

      • North America
        • North America Cell Surface Makers Market, By Product
        • North America Cell Surface Makers Market, By Application
        • North America Cell Surface Makers Market, By Country
          • U.S.
          • Canada
      • Europe
        • Europe Cell Surface Makers Market, By Product
        • Europe Cell Surface Makers Market, By Application
        • Europe Cell Surface Makers Market, By Country
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
        • Asia Pacific Cell Surface Makers Market, By Product
        • Asia Pacific Cell Surface Makers Market, By Application
        • Asia Pacific Cell Surface Makers Market, By Country
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
        • Latin America Cell Surface Makers Market, By Product
        • Latin America Cell Surface Makers Market, By Application
        • Latin America Cell Surface Makers Market, By Country
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
        • Middle East & Africa Cell Surface Makers Market, By Product
        • Middle East & Africa Cell Surface Makers Market, By Application
        • Middle East & Africa Cell Surface Makers Market, By Country
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Cell Surface Makers Market Key Players

The key players operating the global cell surface makers market involves Thermo Fisher Scientific, QIAGEN N.V., Becton, Dickinson and Company, F. Hoffman-La Roche, Bio-Rad Laboratories, Danaher Corporation, Abcam, GenScript , BioLegend, Cell Signaling Technology (US), Merck KGaA, and Bio-Techne . In January 2019, BD announced the commercial availability of their new kits which is specially designed for the identification and quantification of the information of the cells.  In May 2019, GE Healthcare announced the launch of their Cryochain software that is specially designed for the cell therapy. The main aim is to reduce development process and therapy. On Sep 7, year 2018, Thermo Fisher Scientific acquired the Advanced Bioprocessing business of Becton, Dickinson and Company. This will be integrated into the Life Sciences Solutions segment of Thermo Fisher.

Global Cell Surface Makers Market Company Profile

      • Thermo Fisher Scientific
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • QIAGEN N.V.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • Becton, Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • F. Hoffman-La Roche
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • Bio-Rad Laboratories
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • Danaher Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • Abcam, GenScript
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • BioLegend
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • Cell Signaling Technology
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • Merck KGaA
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
  • Bio-Techne
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance

Global Cell Surface Makers Market Table of Contents

Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Industry Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Cell Surface Makers Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Products
      • Market Snippet, By Application
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Cell Surface Makers Market, By Products, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Flow Cytometry
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Hematology Analyzers
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cell Imaging Systems
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Reagents and Kits
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Cell Surface Makers Market, By Application, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Disease Diagnosis
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Research and Drug Discovery
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Cell Surface Makers Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Products, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Products, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Products, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Products, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Products, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  9. Company Profiles
      • Thermo Fisher Scientific
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • QIAGEN N.V.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Becton, Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • F. Hoffman-La Roche
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Bio-Rad Laboratories
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Danaher Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Abcam
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • . GenScript
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • BioLegend
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
      • Cell Signaling Technology
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
  10. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The Global Cell Surface Markers Market is valued at US$560.35 million in 2020

The Global Cell Surface Markers Market is projected to increase at a CAGR of 7.5% during the forecast period.

The global cell surface makers market is segmented based on product, application, and region

The factors that drive the growth of the global cell surface market are advancement in healthcare technology and growing inclination towards minimizing healthcare expenditure by reducing the cost associated with diagnosis.